BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34937659)

  • 21. Combination treatment with artemisinin and oxaliplatin inhibits tumorigenesis in esophageal cancer EC109 cell through Wnt/β-catenin signaling pathway.
    Wang T; Wang J; Ren W; Liu ZL; Cheng YF; Zhang XM
    Thorac Cancer; 2020 Aug; 11(8):2316-2324. PubMed ID: 32657048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma.
    Shen DY; Zhang W; Zeng X; Liu CQ
    Cancer Sci; 2013 Oct; 104(10):1303-8. PubMed ID: 23822562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
    Zhang C; Zhang Z; Zhang S; Wang W; Hu P
    Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACBP suppresses the proliferation, migration, and invasion of colorectal cancer via targeting Wnt/beta-catenin signaling pathway.
    Tong X; Zhuang Z; Wang X; Yang X; Bai L; Su L; Wei P; Su X
    Biomed Pharmacother; 2021 May; 137():111209. PubMed ID: 33581651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Saponin from Tupistra chinensis Baker on proliferation and apoptosis of ovarian cancer cells by Wnt/β-Catenin pathway.
    Ji X; Yang C; Xie J; Yin X; Hu Q
    IUBMB Life; 2020 Aug; 72(8):1780-1786. PubMed ID: 32502299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
    PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
    Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer.
    Yang X; Pan Q; Lu Y; Jiang X; Zhang S; Wu J
    Cell Biol Int; 2019 Apr; 43(4):402-408. PubMed ID: 30614606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hcrcn81 promotes cell proliferation through Wnt signaling pathway in colorectal cancer.
    Chen Y; Jiang T; Shi L; He K
    Med Oncol; 2016 Jan; 33(1):3. PubMed ID: 26607374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of LncRNA CRNDE suppresses proliferation and P-glycoprotein-mediated multidrug resistance in acute myelocytic leukemia through the Wnt/β-catenin pathway.
    Kang Y; Zhang S; Cao W; Wan D; Sun L
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
    Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
    J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
    Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
    Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lawsone derivatives target the Wnt/β-catenin signaling pathway in multidrug-resistant acute lymphoblastic leukemia cells.
    Hamdoun S; Fleischer E; Klinger A; Efferth T
    Biochem Pharmacol; 2017 Dec; 146():63-73. PubMed ID: 29061340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation.
    Liu HR; Zhao J
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):94-107. PubMed ID: 33506897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guizhi Fuling Capsule inhibits uterine fibroids growth by modulating Med12-mediated Wnt/β-Catenin signaling pathway.
    Chen L; Chen H; Yang Q; Jiang Y; Liu L; Yu H; Chen Y; Li J; Chen N; Wang H; Wang Q
    J Ethnopharmacol; 2022 May; 290():115115. PubMed ID: 35181487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-cell translocation gene 3 overexpression inhibits proliferation and invasion of colorectal cancer SW480 cells via Wnt/β-catenin signaling pathway.
    Mao D; Qiao L; Lu H; Feng Y
    Neoplasma; 2016; 63(5):705-16. PubMed ID: 27468874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells.
    Srivastava NS; Srivastava RAK
    Phytomedicine; 2019 Jan; 52():117-128. PubMed ID: 30599890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.